Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-28 19:42:57 - browse：6415

Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.

Additionally, Apellis confirmed one additional case of the severe and potentially blinding side effect, known as retinal occlusive vasculitis, or ROV, that occurred in May. But with thousands of more Syfovre eye injections also performed, the overall frequency of ROV remains unchanged and rare, even with the added scrutiny and increased physician monitoring.

Apellis shares rose 30% to $40 in Wednesday’s pre-market trading on the growing belief amongst investors that Syfovre’s safety crisis is abating.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： The best solution to the drug shortages problem

leisure time

WSS

HHS names first

How to use technology to prevent future drug shortages

Wegovy trial has doctors encouraged over new possibilities

American woman, child freed after being kidnapped in Haiti last month

Idaho abortion case may prompt more restrictions in other states

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

hotspot

Wikipedia

focus

Medical records are filled with copy

Designating disabled people as health disparity population is crucial

ChatGPT in medicine: STAT answers readers' burning questions

Health and fitness trackers are measuring the wrong things

Apple is now the first public company to be valued at $3 trillion

New England Journal of Medicine addresses racist history, slavery

Jerome Adams on the need for new antivirals for Covid

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Psychedelics group wrestles with new pharma identity

JPM 2024: Verve Therapeutics looks to mainstream genome editing

hotspot

NIH trials fail to test meaningful long Covid therapies, experts say

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Naloxone nonprofit donates 200,000 doses after FDA approval

Methadone doses haven’t kept up in the age of fentanyl

In same hospitals, Black patients receive fewer opioids than white patients

How I ended up pumping milk in a bathroom stall at JPM 2024

hotspot

focus

leisure time

entertainment